Literature DB >> 21601789

A global perspective on gastrointestinal diseases.

Radha Menon1, Andres Riera, Asyia Ahmad.   

Abstract

Common gastrointestinal diseases often exhibit geographic, cultural, and gender variations. Diseases previously less common in certain areas of the world have shown a recent increase in prevalence. Industrialization has traditionally been noted as a major cause for this epidemiologic evolution. However, environmental factors such as diet, hygiene, and exposure to infections may play a major role. Moreover, the way one disease presents in a certain location may vary significantly from the way it manifests in another culture or location. This article discusses global variations of inflammatory bowel disease, Helicobacter pylori, irritable bowel disease, fecal incontinence, hepatitis B, and hepatocellular cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21601789     DOI: 10.1016/j.gtc.2011.03.002

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  6 in total

1.  The Treatment of Constipation-Predominant Irritable Bowel Syndrome with Acupuncture and Moxibustion: A Case Report.

Authors:  Joyce K Anastasi; Bernadette Capili
Journal:  J Chin Med       Date:  2012-06

2.  A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis.

Authors:  Hongping Yu; Hongliang Liu; Li-E Wang; Qingyi Wei
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

3.  Association of TLR4 and Treg in Helicobacter pylori Colonization and Inflammation in Mice.

Authors:  Yanfeng Gong; Liming Tao; Lei Jing; Dongsheng Liu; Sijun Hu; Wei Liu; Nanjin Zhou; Yong Xie
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

4.  Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.

Authors:  Jolien J M Freriksen; Jody Salomon; Hennie M J Roelofs; Rene H M Te Morsche; Jos W J van der Stappen; Polat Dura; Ben J M Witteman; Martin Lacko; Wilbert H M Peters
Journal:  J Hum Genet       Date:  2014-05-15       Impact factor: 3.172

5.  Helicobacter pylori infection and light chain gammopathy.

Authors:  José A Girón; Shawn L Shah
Journal:  Clin Dev Immunol       Date:  2013-12-02

6.  Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: A double-blind controlled study.

Authors:  Hamed Daghaghzadeh; Fateme Naji; Hamid Afshar; Mohammad Reza Sharbafchi; Awat Feizi; Mohsen Maroufi; Mahshid Tabatabaeeyan; Peyman Adibi; Hamid Tavakoli
Journal:  J Res Med Sci       Date:  2015-06       Impact factor: 1.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.